Clinical Professor Tan is a Transplant Infectious Disease physician. He obtained a PhD in Microbiology after his advanced training in Internal Medicine and Infectious Diseases (ID). He established the ACGME-I senior residency ID program in his hospital in 2012 and was its first Program Director. He served as Head ID at Singapore General Hospital (SGH) from 2014 to 2023. His clinical and academic work focuses on immunocompromised hosts, especially those with hematopoietic and solid organ transplants. He co-directed the SGH COVID-19 pandemic response and served in various national COVID-19-related workgroups during the pandemic, including as deputy co-chair of the MOH COVID-19 Transplantation Services Advisory Committee. He is currently a member of several regulatory committees Singapore's Health Sciences Authority and has served on several advisory boards of industry partners.

In recognition of his contributions to clinical excellence, public health and medical education, Dr Tan has received numerous accolades, including the Outstanding Faculty Award, the Public Administration Medal (Bronze), the SingHealth GCEO Excellence Award (Outstanding Clinician Award), the SingHealth Quality Service Award and the Public Administration Medal (Silver) (COVID-19). In 2025, he was inducted into the Hall of Master Academic Clinicians at Duke-NUS Medical School, underscoring his enduring impact on medical education and infectious disease leadership.

Dr Tan's commitment to clinical excellence is rooted in his core interest in Transplant Infectious Diseases, where he strives to uphold the highest standards of infection prevention, patient safety and posttransplant care.

Prof Benjamin Teh is an infectious diseases physician and researcher at Peter MacCallum Cancer Centre, Melbourne, Australia who has made a series of globally significant, practice-changing contributions to advance management of infections in haematology patients with the introduction of immune-based therapies.

A/Prof Teh has published extensively with 100 peer reviewed publications in leading journals including New England Journal of Medicine, Lancet Infectious Diseases and Clinical Infectious Diseases. Amongst other awards, he is the recipient of the Victorian Premier’s Clinical Researcher Prize for Health and Medical Research, University of Melbourne Chancellor’s PhD Prize for 2018 and the International Immunocompromised Host Society Young Investigator Award 2022 in recognition of research quality and impact. He contributes to the field as an Associate Editor for Transplant Infectious Diseases. A/Prof. Teh leads research, national and international groups including being chair of the Australasian Society for Infectious Diseases Immunocompromised Host Special Interest Group. He has advanced international research practice through development of consensus core reporting dataset for infections in immunocompromised patients with 7 specialist societies including TID section of TTS. In addition, he drives translation of evidence to health policy as a technical immunisation advisor to the Australian Government, ensuring consideration and equity for immunocompromised patients.